Navigation Links
FDA Approves New Drug to Treat Type I and Type II Diabetes

still need better blood sugar control; will follow their doctor's instructions exactly; will follow-up with their doctor often; will test their blood sugar levels before and after every meal, and at bedtime; and understand how to adjust Symlin and insulin doses.

Symlin should not be used if patients cannot tell when their blood sugar is low, have gastroparesis (slow stomach emptying), or are allergic to pramlintide acetate, metacresol, D-mannitol, acetic acid, or sodium acetate.

Side effects associated with Symlin include but are not limited to nausea, vomiting, abdominal pain, headache, fatigue and dizziness.

Symlin has not been evaluated in the pediatric population.

Symlin is manufactured by Amylin Pharmaceuticals, Inc. of San Diego, California.


'"/>

Source:US FDA


Page: 1 2

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. FDA Approves New Treatment for Chronic Hepatitis B
3. Discovery Could Lead To Novel Approaches In HIV Treatment
4. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss
7. Effective Cancer Treatments Follow The Clock
8. FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain
9. Potential Drug Target For Treating Cocaine Abuse Found
10. Protein Discovery Could Unlock The Secret To Better TB Treatment
11. Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers
Post Your Comments:
(Date:7/1/2009)...e European Molecular Biology Laboratory,s European... a major new e-science resource for biologists wh...H1N1 flu and cancer. , Biocatalogue.org , a cen...ices, is being officially launched today (Wednesda...nce on Intelligent Systems for Molecular Biology a...
(Date:7/1/2009)...ciation has released an updated position paper on ...l-planned, are healthful and nutritious for adults...revent and treat chronic diseases including heart ...osition, published in the July issue of the Journ...ts the Association,s official stance on vegetarian...
(Date:7/1/2009)...gest study to date of endometriosis in pregnant wo...actor for premature birth, the 25th annual confere...and Embryology heard today (Wednesday July 1). Dr....hild Health, Karolinska Institute, Stockholm, Swed...ndometriosis also had a higher risk of other pregn...
(Date:6/30/2009)...lth" halo surrounding highly-publicized marketing ...arting to dim. , Recent announcements by Starbuc...ctose corn syrup from certain products are being c...perts and respected journalists. These articles h...d put forth scientifically substantiated facts abo...
Breaking Biology News(10 mins):New e-science service could accelerate cancer research 2ADA releases updated position paper on vegetarian diets 2Women with endometriosis need special care during pregnancy to avoid risk of premature birth 2Recent news reports of sweetener reformulations raise questions about motivations 2NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference 45003 1NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference 45003 2NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference 45003 3Jazz Pharmaceuticals Inc Announces First Quarter 2009 Financial Results 45001 1Jazz Pharmaceuticals Inc Announces First Quarter 2009 Financial Results 45001 2Jazz Pharmaceuticals Inc Announces First Quarter 2009 Financial Results 45001 3Jazz Pharmaceuticals Inc Announces First Quarter 2009 Financial Results 45001 4Jazz Pharmaceuticals Inc Announces First Quarter 2009 Financial Results 45001 5Jazz Pharmaceuticals Inc Announces First Quarter 2009 Financial Results 45001 6Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus 44999 1Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus 44999 2Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus 44999 3Cancer Patients in North Wales to Gain Access to Varians RapidArc Radiotherapy Treatments 44997 1Cancer Patients in North Wales to Gain Access to Varians RapidArc Radiotherapy Treatments 44997 2
...emy Research Fellow Michael Courtney has identifie...is a factor in the degeneration of brain cells, wh...l conditions and diseases, such as Alzheimer,s dis...based at the A. I. Virtanen Institute of the Unive... Coffey,s team at the Turku Centre for Biotechnolo...
...f Manchester believe injections of tiny sponge-lik...surgery in the treatment of chronic lower back pai...s and Professor Tony Freemont from The Faculty of ... particles that swell and stiffen when injected in...led that degenerated animal intervertebral discs c...
...ion of its new cigarette brand seems to promise a ...ith smoking," the company boasts on its Web site, ...ecided not to quit, but who are interested in a ci...oking-related illnesses, including cancer." Anothe...rowed "All of the taste ?Less of the toxins." , B...
...chers have discovered a genetic cause of a mysteri...ble recalling and using words. The illness, Primar...sease in which a person,s memory becomes impaired....lose the ability to express themselves and underst...e, provides a molecular approach to understanding ...
Other Biology News:Researchers hot on the trail of brain cell degeneration 2Swell gel could bring relief to back pain sufferers 2New cigarette designs don't offer lower predicted cancer risks 2New cigarette designs don't offer lower predicted cancer risks 3Researchers discover genetic cause for word-finding disease 2
(Date:7/1/2009)..., Single-dose of investigational sustained follicl...ections of follitropin beta given over a one week ... Schering-Plough Corp., ...ase III ENGAGE clinical trial demonstrating that a...n the class of sustained follicle stimulants, achi...
(Date:7/1/2009)..., ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswi... ) today announced that it expects to have top-lin...-52, the first of two pivotal Phase 3 clinical tri...t-B(R)) in systemic lupus erythematosus (SLE). ,...h/20080416/HGSLOGO ) , , Senior management w...
(Date:6/30/2009)... , , , , CITY OF INDUSTRY, Calif. and HONG ...h Holdings, Inc. (Pink Sheets: EFTB), announced to...ompleted its inaugural Taiwan Strait passenger voy...ticles and internet news sites, including the Taiw...: , , "A Taiwan company launched a cruise serv...
(Date:6/30/2009)..., Second Quarter 2009 Earnings Conference Call Tue..., FRAZER, Pa., June 30 ... regular quarterly earnings conference call coveri...n Tuesday, August 4, 2009. , , August 4, 200...lts will be distributed by PRNewswire, 4:50 p....
Breaking Biology Technology:Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 3
...ee-area company that makes analytical devices for ...vestment from local angel group Silicon Pastures. ... various sensors for water, waste-water, food, bev...tions can be attached to a standard "stick" device...f its main selling points is the modularity of the...
...enue up 86 percent and a narrowed net loss for its...ation hardware and software for business, governme...lion, compared to last year,s $4.4 million. The co...improvement over last year,s $5.4 million loss. , ...ase, which also involved increasing sales, marketi...
...ncer death sentence. , ,Of the approximately 12,00...e U.S., half will die within a year, and the rest ...urvival limits are exceptionally invasive surgerie... the maximum tolerated dose - all of which leads t..., researchers are racing to find better therapies ...
...l investors has been "cleaned up" to make it more ...s an incentives package for investors in early-sta... apply for tax credits of 25 percent of their inve...ean-up bill, signed by the governor on Wednesday, ... from out-of-state or have differing tax situation...
Other Biology Technology:Radiology advance points way to non-invasive brain-cancer treatment 2
Rabbit anti-Junctophilin-4 (C-term)
...ing Kits are designed to speed up the PCR cloning ...dless of sequence or type of polymerase used, are ...se that are difficult to clone by other PCR clonin...ntially detrimental proteins can be cloned and mai...
Size & Applications: 20 ml Storage Temp.: -20C Shelf Life: 12 months
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA.
Biology Products: